Recruiting OBSERVATIONAL NCT05375591

AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer (AI-SONAR)

Artificial Intelligence & Radiomics for Stratification Of Lung Nodules After Radically Treated Cancer (AI-SONAR)

Sponsor: Imperial College London

Conditions Indeterminate Pulmonary Nodules Lung Cancer Lung Metastases Second Primary Cancer

Updated 3 times since 2022 Last updated: May 17, 2022 Started: Oct 13, 2021 Primary completion: Nov 1, 2022 Completion: Nov 1, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05375591, this observational or N/A phase trial focuses on Indeterminate Pulmonary Nodules and Lung Cancer and remains actively recruiting participants. Sponsored by Imperial College London, it has been updated 3 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2022 — Jul 2024 [monthly]

Recruiting

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Imperial College London
Institute of Cancer Research, United Kingdom
National Heart and Lung Institute
National Institute for Health Research, United Kingdom
Oxford University Hospitals NHS Trust
Royal Brompton & Harefield NHS Foundation Trust
Royal Marsden NHS Foundation Trust
Royal Marsden Partners Cancer Alliance

Data source: Royal Marsden NHS Foundation Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom